Effect of Acute Exercise on Prostate Cancer Cell Growth

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Rundqvist, Helene ^a   Augsten, Martin ^a   Strömberg, Anna ^a   Rullman, Eric ^a   Mijwel, Sara ^a   Kharaziha, Pedram ^a   Panaretakis, Theocharis ^a   Gustafsson, Thomas ^a   Östman, Arne ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; MITOGENIC AGENT; SOMATOMEDIN;

ADULT; APOPTOSIS; ARTICLE; BICYCLE ERGOMETRY; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; ENDURANCE TRAINING; EXERCISE; GROWTH HORMONE BLOOD LEVEL; HUMAN; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PHYSICAL ACTIVITY; PROSTATE CANCER; RISK REDUCTION; SCID MOUSE;

ADOLESCENT; ADULT; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; EPIDERMAL GROWTH FACTOR; EXERCISE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; PROSTATIC NEOPLASMS; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS; YOUNG ADULT;

MUS;

EID: 84879819753     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067579     Document Type: Article

References (35)

1. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Jemal A, (2010) Center MM, DeSantis C, Ward EM (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 19: 1893-1907.
3. Kushi LH, Doyle C, McCullough M, Rock CL, Demark-Wahnefried W, et al. (2012) American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 62: 30-67.
4. Liu Y, Hu F, Li D, Wang F, Zhu L, et al. (2011) Does physical activity reduce the risk of prostate cancer? A systematic review and meta-analysis. Eur Urol 60: 1029-1044.
5. Giovannucci EL, Liu Y, Leitzmann MF, Stampfer MJ, Willett WC, (2005) A prospective study of physical activity and incident and fatal prostate cancer. Arch Intern Med 165: 1005-1010.
6. Nilsen TI, Romundstad PR, Vatten LJ, (2006) Recreational physical activity and risk of prostate cancer: A prospective population-based study in Norway (the HUNT study). Int J Cancer 119: 2943-2947.
7. Orsini N, Bellocco R, Bottai M, Pagano M, Andersson SO, et al. (2009) A prospective study of lifetime physical activity and prostate cancer incidence and mortality. Br J Cancer 101: 1932-1938.
8. McTiernan A, (2008) Mechanisms linking physical activity with cancer. Nat Rev Cancer 8: 205-211.
9. Hsing AW, Chua S Jr, Gao YT, Gentzschein E, Chang L, et al. (2001) Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J Natl Cancer Inst 93: 783-789.
10. Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, et al. (2008) Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med 149: 461-471, W483-468.
11. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, et al. (1998) Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279: 563-566.
12. Lehrer S, Diamond EJ, Stagger S, Stone NN, Stock RG, (2002) Increased serum insulin associated with increased risk of prostate cancer recurrence. Prostate 50: 1-3.
13. Hackney AC, Sinning WE, Bruot BC, (1988) Reproductive hormonal profiles of endurance-trained and untrained males. Med Sci Sports Exerc 20: 60-65.
14. Hellenius ML, Brismar KE, Berglund BH, de Faire UH, (1995) Effects on glucose tolerance, insulin secretion, insulin-like growth factor 1 and its binding protein, IGFBP-1, in a randomized controlled diet and exercise study in healthy, middle-aged men. J Intern Med 238: 121-130.
15. Tymchuk CN, Barnard RJ, Heber D, Aronson WJ, (2001) Evidence of an inhibitory effect of diet and exercise on prostate cancer cell growth. J Urol 166: 1185-1189.
16. Ngo TH, Barnard RJ, Tymchuk CN, Cohen P, Aronson WJ, (2002) Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States). Cancer Causes Control 13: 929-935.
17. Pritzlaff CJ, Wideman L, Weltman JY, Abbott RD, Gutgesell ME, et al. (1999) Impact of acute exercise intensity on pulsatile growth hormone release in men. J Appl Physiol 87: 498-504.
18. Weinstock C, Konig D, Harnischmacher R, Keul J, Berg A, et al. (1997) Effect of exhaustive exercise stress on the cytokine response. Med Sci Sports Exerc 29: 345-354.
19. Ostrowski K, Hermann C, Bangash A, Schjerling P, Nielsen JN, et al. (1998) A trauma-like elevation of plasma cytokines in humans in response to treadmill running. J Physiol 513 (Pt 3): 889-894.
20. Northoff H, Berg A, (1991) Immunologic mediators as parameters of the reaction to strenuous exercise. Int J Sports Med 12Suppl 1: S9-15.
21. Berg U, Bang P, (2004) Exercise and circulating insulin-like growth factor I. Horm Res. 62Suppl 1: 50-58.
22. Schwarz AJ, Brasel JA, Hintz RL, Mohan S, Cooper DM, (1996) Acute effect of brief low- and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men. J Clin Endocrinol Metab 81: 3492-3497.
23. Rundqvist H, Rullman E, Sundberg CJ, Fischer H, Eisleitner K, et al. (2009) Activation of the erythropoietin receptor in human skeletal muscle. Eur J Endocrinol 161: 427-434.
24. Augsten M, Hagglof C, Olsson E, Stolz C, Tsagozis P, et al. (2009) CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth. Proc Natl Acad Sci U S A 106: 3414-3419.
25. Ullen A, Farnebo M, Thyrell L, Mahmoudi S, Kharaziha P, et al. (2010) Sorafenib induces apoptosis and autophagy in prostate cancer cells in vitro. Int J Oncol 37: 15-20.
26. Tuxhorn JA, McAlhany SJ, Dang TD, Ayala GE, Rowley DR, (2002) Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Cancer Res 62: 3298-3307.
27. Barnard RJ, Leung PS, Aronson WJ, Cohen P, Golding LA, (2007) A mechanism to explain how regular exercise might reduce the risk for clinical prostate cancer. Eur J Cancer Prev 16: 415-421.
28. Schuurmans AL, Bolt J, Veldscholte J, Mulder E, (1991) Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones. J Steroid Biochem Mol Biol 40: 193-197.
29. Schlomm T, Kirstein P, Iwers L, Daniel B, Steuber T, et al. (2007) Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer. Clin Cancer Res 13: 6579-6584.
30. Sridhar SS, Hotte SJ, Chin JL, Hudes GR, Gregg R, et al. (2010) A multicenter phase II clinical trial of lapatinib (GW572016) in hormonally untreated advanced prostate cancer. Am J Clin Oncol 33: 609-613.
31. Jones JI, Clemmons DR, (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16: 3-34.
32. Mantzoros CS, Tzonou A, Signorello LB, Stampfer M, Trichopoulos D, et al. (1997) Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br J Cancer 76: 1115-1118.
33. Barnard RJ, Ngo TH, Leung PS, Aronson WJ, Golding LA, (2003) A low-fat diet and/or strenuous exercise alters the IGF axis in vivo and reduces prostate tumor cell growth in vitro. Prostate 56: 201-206.
34. Ngo TH, Barnard RJ, Leung PS, Cohen P, Aronson WJ, (2003) Insulin-like growth factor I (IGF-I) and IGF binding protein-1 modulate prostate cancer cell growth and apoptosis: possible mediators for the effects of diet and exercise on cancer cell survival. Endocrinology 144: 2319-2324.
35. Galvao DA, Nosaka K, Taaffe DR, Peake J, Spry N, et al. (2008) Endocrine and immune responses to resistance training in prostate cancer patients. Prostate Cancer Prostatic Dis 11: 160-165.